EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasites

Emma Y Mao iD, William Nguyen, Gouranga P Jana, Bikash C Maity, Samuel Pazicky, Carlo Giannangelo, Janette Reader, Mufuliat T Famodimu, Lyn-Marie Birkholtz, Michael J Delves, Darren J Creek iD, Zbynek Bozdech und 5 weitere

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01783-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Emma Y Mao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Infectious Diseases, School of Biological Sciences, The University of Adelaide, Adelaide, Australia. Hauptthemen laut MEDLINE: Azithromycin, Antimalarials, Plasmodium falciparum. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian Research Council, Hospital Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance is steadily undermining the efficacy of frontline anti-malarials, highlighting the urgent need for novel therapies with alternative mechanisms of action. The chemical addition of different moieties to azithromycin yields compounds with improved quick-killing potency against malaria parasites, with the most active analogs typically containing a chloroquinoline group. Here, we investigated the quick-killing mechanism of five azithromycin analogs, two of which contain differentially oriented chloroquinoline moieties. The improvement in quick-killing activity over azithromycin for non-chloroquinoline analogs was around 10 -to 42-fold, with chloroquinoline-containing analogs showing a further 2- to 17-fold improvement over non-chloroquinoline compounds. Chemical inhibition of hemoglobin digestion and chloroquine’s inhibitory effect against heme polymerization linked analogs with both chloroquinoline and non-chloroquinoline modifications to a chloroquine-like mechanism of action. However, none of the analogs showed a significant reduction in efficacy against chloroquine-resistant asexual blood-stage parasites. Multiple attempts at selecting for azithromycin analog-resistant parasites to elucidate the mechanism of quick-killing were unsuccessful. Application of cellular thermal shift proteomics revealed that azithromycin analogs significantly stabilized 34–155 different proteins in trophozoites, a high number that showed minimal overlap with chloroquine. Additionally, our most potent chloroquinoline-containing analog demonstrated a significant improvement in gametocytocidal activity over azithromycin and further maintained moderate inhibition of chloroquine-insensitive late-stage gametocytes. These findings support that this class of azithromycin analogs kills malaria parasites through a broad range of potential mechanisms, making them promising candidates for optimization as fast and broad-acting anti-malarials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinAntimalarialsPlasmodium falciparumChloroquineDrug ResistanceHumansParasitic Sensitivity Tests

Stichwörter der Autor:innen

Plasmodiumantimalarial agentsazithromycincellular thermal shift assaymalaria

Substanzen

AzithromycinAntimalarialsChloroquine

Autor:innen und Institutionen

  • Research Centre for Infectious Diseases, School of Biological Sciences, The University of Adelaide, Adelaide, Australia.
  • ARC Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance (CEA StAR), Brisbane, Australia.
  • Institute for Photonics and Advanced Sensing (IPAS), The University of Adelaide, Adelaide, South Australia, Australia.
  • Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.
  • TCG Lifesciences Private Limited, Salt-lake Electronics Complex, Kolkata, India.

ORCID-Profile: Emma Y Mao, Darren J Creek, Brad E Sleebs, Danny W Wilson

Förderung

  • National Health and Medical Research Council
  • Australian Research Council
  • Hospital Research Foundation
  • Medicines for Malaria Venture
  • UK Research and Innovation
  • South African National Research Foundation

Zitieren

APA

Mao, E. Y., Nguyen, W., Jana, G. P., Maity, B. C., Pazicky, S., Giannangelo, C., Reader, J., Famodimu, M. T., Birkholtz, L. M., Delves, M. J., Creek, D. J., Bozdech, Z., Laleu, B., Burrows, J. N., Sleebs, B. E., Gancheva, M. R., & Wilson, D. W. (2025). Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasites. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01783-24

Vancouver

Mao EY, Nguyen W, Jana GP, Maity BC, Pazicky S, Giannangelo C, et al. Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasites. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01783-24

BibTeX
@article{Mao2025,
  author = {Mao, Emma Y and Nguyen, William and Jana, Gouranga P and Maity, Bikash C and Pazicky, Samuel and Giannangelo, Carlo and Reader, Janette and Famodimu, Mufuliat T and Birkholtz, Lyn-Marie and Delves, Michael J and Creek, Darren J and Bozdech, Zbynek and Laleu, Benoît and Burrows, Jeremy N and Sleebs, Brad E and Gancheva, Maria R and Wilson, Danny W},
  title = {Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasites},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01783-24}
}
Kostenlos starten →